HAZARDS AND COMPLICATIONS OF BCG IMMUNOTHERAPY

被引：79

作者：

SPARKS, FC ^{[1
]}

机构：

[1] UNIV CALIF LOS ANGELES, SCH MED, DIV ONCOL, LOS ANGELES, CA 90024 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1976年 / 60卷 / 03期

关键词：

D O I：

10.1016/S0025-7125(16)31894-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：499 / 509

页数：11

共 64 条

[41]

MEYER J, 1954, AM REV TUBERC PULM, V70, P402

[42]

MORTON DL, 1970, SURGERY, V68, P158

[43]

NATHANSON L, 1972, CANCER CHEMOTH REP 1, V56, P659

[44]

OLD LJ, 1961, CANCER RES, V21, P1281

[45]

PILCH YH, 1975, CURRENT PROBLEMS JAN

[46]

PINSKY CM, 1973, 39 NATL CANC I MON, P225

[47] SYSTEMIC INFECTION FOLLOWING BCG THERAPY [J].

ROSENBERG, EB ;

KANNER, SP ;

SCHWARTZMAN, RJ ;

COLSKY, J .

ARCHIVES OF INTERNAL MEDICINE, 1974, 134 (04) :769-770

[48] SERUM TRANSAMINASE ELEVATIONS AND OTHER HEPATIC ABNORMALITIES IN PATIENTS RECEIVING ISONIAZID [J].

SCHARER, L ;

SMITH, JP .

ANNALS OF INTERNAL MEDICINE, 1969, 71 (06) :1113-+

[49]

SPARKS FC, 1975, SURG FORUM, V26, P162

[50] COMPLICATIONS OF BCG IMMUNOTHERAPY IN PATIENTS WITH CANCER [J].

SPARKS, FC ;

SILVERST.MJ ;

HUNT, JS ;

HASKELL, CM ;

PILCH, YH ;

MORTON, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (16) :827-830

← 1 2 3 4 5 6 7 →